These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 35805135)
1. The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities. Fu X; Liu H; Liu J; DiSanto ME; Zhang X Cells; 2022 Jun; 11(13):. PubMed ID: 35805135 [TBL] [Abstract][Full Text] [Related]
2. Glucose-regulated protein 78 modulates cell growth, epithelial-mesenchymal transition, and oxidative stress in the hyperplastic prostate. Fu X; Liu J; Liu D; Zhou Y; Guo Y; Wang Z; Yang S; He W; Chen P; Wang X; DiSanto ME; Zhang X Cell Death Dis; 2022 Jan; 13(1):78. PubMed ID: 35075122 [TBL] [Abstract][Full Text] [Related]
3. Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer. Ratajczak W; Lubkowski M; Lubkowska A Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055079 [TBL] [Abstract][Full Text] [Related]
4. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828 [TBL] [Abstract][Full Text] [Related]
5. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Nicholson TM; Ricke WA Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560 [TBL] [Abstract][Full Text] [Related]
6. Chemokines and BPH/LUTS. Macoska JA Differentiation; 2011; 82(4-5):253-60. PubMed ID: 21600689 [TBL] [Abstract][Full Text] [Related]
7. The role of prostate inflammation and fibrosis in lower urinary tract symptoms. Bushman WA; Jerde TJ Am J Physiol Renal Physiol; 2016 Oct; 311(4):F817-F821. PubMed ID: 27440781 [TBL] [Abstract][Full Text] [Related]
8. Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy. Dos Santos L; Carbone F; Pacreau E; Diarra S; Luka M; Pigat N; Baures M; Navarro E; Anract J; Barry Delongchamps N; Cagnard N; Bost F; Nemazanyy I; Petitjean O; Hamaï A; Ménager M; Palea S; Guidotti JE; Goffin V Am J Pathol; 2024 Jan; 194(1):30-51. PubMed ID: 37827216 [TBL] [Abstract][Full Text] [Related]
9. S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate. Yang L; Liu J; Yin J; Li Y; Liu J; Liu D; Wang Z; DiSanto ME; Zhang W; Zhang X Int J Biochem Cell Biol; 2024 Apr; 169():106551. PubMed ID: 38360265 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of prostate peripheral zone thickness with benign prostatic hyperplasia/ lower urinary tract symptoms: An update]. Kong B; Hou X; Yang JY Zhonghua Nan Ke Xue; 2019 Aug; 25(8):744-748. PubMed ID: 32227720 [TBL] [Abstract][Full Text] [Related]
11. PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Jiang M; Strand DW; Franco OE; Clark PE; Hayward SW Differentiation; 2011; 82(4-5):220-36. PubMed ID: 21645960 [TBL] [Abstract][Full Text] [Related]
12. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768 [TBL] [Abstract][Full Text] [Related]
13. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway. Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788 [TBL] [Abstract][Full Text] [Related]
14. Role of interleukins, IGF and stem cells in BPH. McLaren ID; Jerde TJ; Bushman W Differentiation; 2011; 82(4-5):237-43. PubMed ID: 21864972 [TBL] [Abstract][Full Text] [Related]
16. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial. Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841 [TBL] [Abstract][Full Text] [Related]
17. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat. Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674 [TBL] [Abstract][Full Text] [Related]
18. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown. Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464 [TBL] [Abstract][Full Text] [Related]
19. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639 [TBL] [Abstract][Full Text] [Related]
20. HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy. Kabakov AE; Gabai VL Cells; 2021 Dec; 10(12):. PubMed ID: 34943954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]